1. Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020) Authors: Bateman, Randall J; Aschenbrenner, Andrew J.; Benzinger, Tammie L.S.; Clifford, David; Coalier, Kelley; Cruchaga, Carlos; Fagan, Anne M.; Farlow, Martin R.; Goate, Alison M.; Gordon, Brian A.; Hassenstab, Jason; Jack, Clifford R.; Koeppe, Robert A.; McDade, Eric; Mills, Susan; Morris, John C.; Sa... Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗